Tejal Vishalpura, PharmD leads the commercial strategy for Novo Nordisk’s innovative cardiometabolic therapy areas, to deliver transformative and human-centered experiences that put patient and customer needs first.

Tejal is passionate about advancing capabilities of employees in support of discovering the potential of modern medicines so that Americans living with serious diseases have an opportunity to unlock their full human potential.

Before joining Novo Nordisk, Tejal held numerous leadership roles at Novartis, including Vice-President, Global Head of Capabilities and Learning as well as Vice-President, Global Head of Marketing and Launch Excellence. She was also a member of their Executive Diversity Council.

Tejal began her post-graduate career at Xcenda, providing corporate and brand strategy consulting for Biotech companies, and held numerous leadership roles at GlaxoSmithKline. Tejal has a Doctor of Pharmacy degree from The Ohio State University.